Sandra Dupouy

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +9

Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression

Frédérique Souazé, Sandra Dupouy, Véronique Viardot-Foucault et al. · Cancer Research · 2006 · 133 citations

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 121 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +10

Neurotensin Receptor 1 Determines the Outcome of Non–Small Cell Lung Cancer

Marco Alifano, Frédérique Souazé, Sandra Dupouy et al. · Clinical Cancer Research · 2010 · 111 citations

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

Sandra Dupouy, Véronique Viardot-Foucault, Marco Alifano et al. · PLoS ONE · 2009 · 86 citations · Full text